Environmental Pollutants and Hydroxysteroid Dehydrogenases

Vitamins and Hormones

Volumn 94, Issue , 2014, Pages 349-390

  Ye, Leping ^a   Guo, Jingjing ^a   Ge, Ren Shan ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

3 HSD, 11 HSD, 17 HSD, and 20 HSD inhibitors; Environmental pollutants; Hydroxysteroid dehydrogenases

Indexed keywords

ENDOCRINE DISRUPTOR; ENZYME INHIBITOR; HYDROXYSTEROID DEHYDROGENASE;

3Β-HSD, 11Β-HSD, 17Β-HSD, AND 20Α-HSD INHIBITORS; ANIMAL; ARTICLE; DRUG ANTAGONISM; HUMAN; METABOLISM; POLLUTANT;

3Β-HSD, 11Β-HSD, 17Β-HSD, AND 20Α-HSD INHIBITORS; ENVIRONMENTAL POLLUTANTS; HYDROXYSTEROID DEHYDROGENASES;

ANIMALS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; ENZYME INHIBITORS; HUMANS; HYDROXYSTEROID DEHYDROGENASES;

EID: 84891474391     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800095-3.00013-4     Document Type: Chapter

References (200)

1. Abdellatif A.G., Preat V., Vamecq J., Nilsson R., Roberfroid M. Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin. Carcinogenesis 1990, 11:1899-1902.
2. Adu-Kumi S., Kares R., Literak J., Boruvkova J., Yeboah P.O., Carboo D., et al. Levels and seasonal variations of organochlorine pesticides in urban and rural background air of southern Ghana. Environmental Science and Pollution Research International 2012, 19:1963-1970.
3. Agarwal A.K., Monder C., Eckstein B., White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. The Journal of Biological Chemistry 1989, 264:18939-18943.
4. Agarwal A.K., Mune T., Monder C., White P.C. Mutations in putative glycosylation sites of rat 11 beta-hydroxysteroid dehydrogenase affect enzymatic activity. Biochimica et Biophysica Acta 1995, 1248:70-74.
5. Agarwal A.K., Rogerson F.M., Mune T., White P.C. Analysis of the human gene encoding the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Journal of Steroid Biochemistry and Molecular Biology 1995, 55:473-479.
6. Agarwal A.K., Rogerson F.M., Mune T., White P.C. Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase. Genomics 1995, 29:195-199.
7. Agarwal A.K., Tusie-Luna M.T., Monder C., White P.C. Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Molecular Endocrinology 1990, 4:1827-1832.
8. Akingbemi B.T., Ge R.S., Klinefelter G.R., Gunsalus G.L., Hardy M.P. A metabolite of methoxychlor, 2,2-bis(p-hydroxyphenyl)-1,1, 1-trichloroethane, reduces testosterone biosynthesis in rat leydig cells through suppression of steady-state messenger ribonucleic acid levels of the cholesterol side-chain cleavage enzyme. Biology of Reproduction 2000, 62:571-578.
9. Akingbemi B.T., Hardy M.P. Oestrogenic and antiandrogenic chemicals in the environment: Effects on male reproductive health. Annals of Medicine 2001, 33:391-403.
10. Akingbemi B.T., Sottas C.M., Koulova A.I., Klinefelter G.R., Hardy M.P. Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 2004, 145:592-603.
11. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology 1994, 105:R11-R17.
12. Albro P.W., Corbett J.T., Schroeder J.L., Jordan S., Matthews H.B. Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environmental Health Perspectives 1982, 45:19-25.
13. Andersson S., Geissler W.M., Wu L., Davis D.L., Grumbach M.M., New M.I., et al. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Journal of Clinical Endocrinology and Metabolism 1996, 81:130-136.
14. Andersson S., Minjarez D., Yost N.P., Word R.A. Estrogen and progesterone metabolism in the cervix during pregnancy and parturition. Journal of Clinical Endocrinology and Metabolism 2008, 93:2366-2374.
15. Arnold P., Tam S., Yan L., Baker M.E., Frey F.J., Odermatt A. Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+. Molecular and Cellular Endocrinology 2003, 201:177-187.
16. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., et al. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 1987, 237:268-275.
17. Atanasov A.G., Ignatova I.D., Nashev L.G., Dick B., Ferrari P., Frey F.J., et al. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: A novel mechanism of apparent mineralocorticoid excess. Journal of the American Society of Nephrology 2007, 18:1262-1270.
18. Atanasov A.G., Nashev L.G., Gelman L., Legeza B., Sack R., Portmann R., et al. Direct protein-protein interaction of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen. Biochimica et Biophysica Acta 2008, 1783:1536-1543.
19. Atanasov A.G., Nashev L.G., Schweizer R.A., Frick C., Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters 2004, 571:129-133.
20. Atanasov A.G., Nashev L.G., Tam S., Baker M.E., Odermatt A. Organotins disrupt the 11beta-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids. Environmental Health Perspectives 2005, 113:1600-1606.
21. Atanasov A.G., Tam S., Rocken J.M., Baker M.E., Odermatt A. Inhibition of 11 beta-hydroxysteroid dehydrogenase type 2 by dithiocarbamates. Biochemical and Biophysical Research Communications 2003, 308:257-262.
22. Austin M.E., Kasturi B.S., Barber M., Kannan K., MohanKumar P.S., MohanKumar S.M. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environmental Health Perspectives 2003, 111:1485-1489.
23. Bain P.A., Meisler M.H., Taylor B.A., Payne A.H. The genes encoding gonadal and nongonadal forms of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase are closely linked on mouse chromosome 3. Genomics 1993, 16:219-223.
24. Banhegyi G., Benedetti A., Fulceri R., Senesi S. Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. The Journal of Biological Chemistry 2004, 279:27017-27021.
25. Benediktsson R., Calder A.A., Edwards C.R., Seckl J.R. Placental 11 beta-hydroxysteroid dehydrogenase: A key regulator of fetal glucocorticoid exposure. Clinical Endocrinology 1997, 46:161-166.
26. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., Edwards C.R. Glucocorticoid exposure in utero: New model for adult hypertension. Lancet 1993, 341:339-341.
27. Bhosle N.B., Garg A., Jadhav S., Harjee R., Sawant S.S., Venkat K., et al. Butyltins in water, biofilm, animals and sediments of the west coast of India. Chemosphere 2004, 57:897-907.
28. Biegel L.B., Liu R.C., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: In vitro, in vivo, and ex vivo studies. Toxicology and Applied Pharmacology 1995, 134:18-25.
29. Binder P.S., Baumgartner S.D., Zavala E.Y., Deg J.K., Grossman K.R. Refractive keratoplasty: Myopic keratomileusis in baboons. Current Eye Research 1984, 3:1187-1197.
30. Blomquist C.H., Lima P.H., Hotchkiss J.R. Inhibition of 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD) activity of human lung microsomes by genistein, daidzein, coumestrol and C(18)-, C(19)- and C(21)-hydroxysteroids and ketosteroids. Steroids 2005, 70:507-514.
31. Blum A., Martin H.J., Maser E. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: Recombinant expression in the yeast Pichia pastoris and Escherichia coli. Toxicology 2000, 144:113-120.
32. Blum A., Martin H.J., Maser E. Human 11beta-hydroxysteroid dehydrogenase type 1 is enzymatically active in its nonglycosylated form. Biochemical and Biophysical Research Communications 2000, 276:428-434.
33. Borst J.G., Ten Holt S.P., De Vries L.A., Molhuysen J.A. Synergistic action of liquorice and cortisone in Addison's and Simmonds's disease. Lancet 1953, 1:657-663.
34. Boxmeer J.C., Smit M., Weber R.F., Lindemans J., Romijn J.C., Eijkemans M.J., et al. Seminal plasma cobalamin significantly correlates with sperm concentration in men undergoing IVF or ICSI procedures. Journal of Andrology 2007, 28:521-527.
35. Brooks J.D., Thompson L.U. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. Journal of Steroid Biochemistry and Molecular Biology 2005, 94:461-467.
36. Brown R.W., Chapman K.E., Kotelevtsev Y., Yau J.L., Lindsay R.S., Brett L., et al. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. The Biochemical Journal 1996, 313(Pt 3):1007-1017.
37. Brown W.M., Metzger L.E., Barlow J.P., Hunsaker L.A., Deck L.M., Royer R.E., et al. 17-beta-Hydroxysteroid dehydrogenase type 1: Computational design of active site inhibitors targeted to the Rossmann fold. Chemico-Biological Interactions 2003, 143-144:481-491.
38. Brozic P., Kocbek P., Sova M., Kristl J., Martens S., Adamski J., et al. Flavonoids and cinnamic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. Molecular and Cellular Endocrinology 2009, 301:229-234.
39. Bujalska I.J., Draper N., Michailidou Z., Tomlinson J.W., White P.C., Chapman K.E., et al. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology 2005, 34:675-684.
40. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environmental Health Perspectives 2005, 113:391-395.
41. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environmental Health Perspectives 2008, 116:39-44.
42. Caprio M., Newfell B.G., la Sala A., Baur W., Fabbri A., Rosano G., et al. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circulation Research 2008, 102:1359-1367.
43. Chang Y.T., Kappy M.S., Iwamoto K., Wang J., Yang X., Pang S. Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. Pediatric Research 1993, 34:698-700.
44. Chen B.B., Lin H., Hu G.X., Su Y., Zhou H.Y., Lian Q.Q., et al. The (+)- and (-)-gossypols potently inhibit human and rat 11beta-hydroxysteroid dehydrogenase type 2. Journal of Steroid Biochemistry and Molecular Biology 2009, 113:177-181.
45. Christy C., Hadoke P.W., Paterson J.M., Mullins J.J., Seckl J.R., Walker B.R. 11beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: Localization and influence on response to glucocorticoids. Hypertension 2003, 42:580-587.
46. Clarke I.J., Rao A., Fallest P.C., Shupnik M.A. Transcription rate of the follicle stimulating hormone (FSH) beta subunit gene is reduced by inhibin in sheep but this does not fully explain the decrease in mRNA. Molecular and Cellular Endocrinology 1993, 91:211-216.
47. Claus R., Lacorn M., Welter H., Lekhkota O., Messe N., Wagner A., et al. Expression of 11beta-hydroxysteroid-dehydrogenase 2 in Sertoli cells of boar testes. Molecular and Cellular Endocrinology 2007, 272:86-92.
48. Cole T.J. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: Tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 1995, 136:4693-4696.
49. Creasy D.M., Beech L.M., Gray T.J., Butler W.H. The ultrastructural effects of di-n-pentyl phthalate on the testis of the mature rat. Experimental and Molecular Pathology 1987, 46:357-371.
50. Deuchar G.A., McLean D., Hadoke P.W., Brownstein D.G., Webb D.J., Mullins J.J., et al. 11beta-Hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice. Endocrinology 2011, 152:236-246.
51. Doi M., Takahashi Y., Komatsu R., Yamazaki F., Yamada H., Haraguchi S., et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nature Medicine 2010, 16:67-74.
52. Doyle L.W., Faber B., Callanan C., Morley R. Blood pressure in late adolescence and very low birth weight. Pediatrics 2003, 111:252-257.
53. Draper N., Walker E.A., Bujalska I.J., Tomlinson J.W., Chalder S.M., Arlt W., et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature Genetics 2003, 34:434-439.
54. Duax W.L., Ghosh D., Pletnev V. Steroid dehydrogenase structures, mechanism of action, and disease. Vitamins and Hormones 2000, 58:121-148.
55. Dunnick J.K., Hailey J.R. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Research 1996, 56:4922-4926.
56. Duperrex H., Kenouch S., Gaeggeler H.P., Seckl J.R., Edwards C.R., Farman N., et al. Rat liver 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. Endocrinology 1993, 132:612-619.
57. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., et al. Localisation of 11 beta-hydroxysteroid dehydrogenase-Tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 2:986-989.
58. Frick C., Atanasov A.G., Arnold P., Ozols J., Odermatt A. Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase. The Journal of Biological Chemistry 2004, 279:31131-31138.
59. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988, 242:583-585.
60. Garbrecht M.R., Krozowski Z.S., Snyder J.M., Schmidt T.J. Reduction of glucocorticoid receptor ligand binding by the 11-beta hydroxysteroid dehydrogenase type 2 inhibitor, Thiram. Steroids 2006, 71:895-901.
61. Ge R.S., Chen G.R., Tanrikut C., Hardy M.P. Phthalate ester toxicity in Leydig cells: Developmental timing and dosage considerations. Reproductive Toxicology 2007, 23:366-373.
62. Ge R.-S., Dong Q., Niu E.-m., Sottas C.M., Hardy D.O., Catterall J.F., et al. 11β-Hydroxysteroid dehydrogenase 2 in rat Leydig cells: Its role in blunting glucocorticoid action at physiological levels of substrate. Endocrinology 2005, 146:2657-2664.
63. Ge R.S., Dong Q., Niu E.M., Sottas C.M., Hardy D.O., Catterall J.F., et al. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: Its role in blunting glucocorticoid action at physiological levels of substrate. Endocrinology 2005, 146:2657-2664.
64. Ge R.S., Dong Q., Sottas C.M., Papadopoulos V., Zirkin B.R., Hardy M.P. In search of rat stem Leydig cells: Identification, isolation, and lineage-specific development. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:2719-2724.
65. Ge R.S., Gao H.B., Nacharaju V.L., Gunsalus G.L., Hardy M.P. Identification of a kinetically distinct activity of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells. Endocrinology 1997, 138:2435-2442.
66. Ge R.S., Hardy M.P. Variation in the end products of androgen biosynthesis and metabolism during postnatal differentiation of rat Leydig cells. Endocrinology 1998, 139:3787-3795.
67. Ge R.S., Hardy M.P. Initial predominance of the oxidative activity of type I 11beta-hydroxysteroid dehydrogenase in primary rat Leydig cells and transfected cell lines. Journal of Andrology 2000, 21:303-310.
68. Geissler W.M., Davis D.L., Wu L., Bradshaw K.D., Patel S., Mendonca B.B., et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nature Genetics 1994, 7:34-39.
69. Ghosh D., Pletnev V.Z., Zhu D.W., Wawrzak Z., Duax W.L., Pangborn W., et al. Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolution. Structure 1995, 3:503-513.
70. Gilliland F.D., Mandel J.S. Mortality among employees of a perfluorooctanoic acid production plant. Journal of Occupational Medicine 1993, 35:950-954.
71. Gomez-Sanchez E.P., Gomez-Sanchez M.T., de Rodriguez A.F., Romero D.G., Warden M.P., Plonczynski M.W., et al. Immunohistochemical demonstration of the mineralocorticoid receptor, 11{beta}-hydroxysteroid dehydrogenase 1 and 2, and hexose-6-phosphate dehydrogenase in rat ovary. Journal of Histochemistry and Cytochemistry 2009, 57:633-641.
72. Gray T.J., Beamand J.A. Effect of some phthalate esters and other testicular toxins on primary cultures of testicular cells. Food and Chemical Toxicology 1984, 22:123-131.
73. Gray T.J., Butterworth K.R. Testicular atrophy produced by phthalate esters. Archives of Toxicology. Supplement 1980, 4:452-455.
74. Gray T.J., Gangolli S.D. Aspects of the testicular toxicity of phthalate esters. Environmental Health Perspectives 1986, 65:229-235.
75. Gray L.E., Ostby J., Ferrell J., Sigmon R., Cooper R., Linder R., et al. Correlation of sperm and endocrine measures with reproductive success in rodents. Progress in Clinical and Biological Research 1989, 302:193-206. Discussion 206-209.
76. Green V.L., Speirs V., Landolt A.M., Foy P.M., Atkin S.L. 17Beta-hydroxysteroid dehydrogenase type 1, 2, 3, and 4 expression and enzyme activity in human anterior pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1999, 84:1340-1345.
77. Gu Y., Lin Y.C., Rikihisa Y. Inhibitory effect of gossypol on steroidogenic pathways in cultured bovine luteal cells. Biochemical and Biophysical Research Communications 1990, 169:455-461.
78. Guo J., Yuan X., Qiu L., Zhu W., Wang C., Hu G., et al. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenases activities by bisphenol A. Toxicology Letters 2012, 215:126-130.
79. Haeussler S., Claus R. Expression of the glucocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase 2 in pig testes cells along fetal development. Reproduction, Fertility, and Development 2007, 19:664-669.
80. Hahn T., Barth S., Graf R., Engelmann M., Beslagic D., Reul J.M., et al. Placental glucose transporter expression is regulated by glucocorticoids. Journal of Clinical Endocrinology and Metabolism 1999, 84:1445-1452.
81. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. The New England Journal of Medicine 1971, 284:878-881.
82. Higaki Y., Usami N., Shintani S., Ishikura S., El-Kabbani O., Hara A. Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. Chemico-Biological Interactions 2003, 143-144:503-513.
83. Hong D., Li X.W., Lian Q.Q., Lamba P., Bernard D.J., Hardy D.O., et al. Mono-(2-ethylhexyl) phthalate (MEHP) regulates glucocorticoid metabolism through 11beta-hydroxysteroid dehydrogenase 2 in murine gonadotrope cells. Biochemical and Biophysical Research Communications 2009, 389:305-309.
84. Hoover R.N., Hyer M., Pfeiffer R.M., Adam E., Bond B., Cheville A.L., et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. The New England Journal of Medicine 2011, 365:1304-1314.
85. Howdeshell K.L., Furr J., Lambright C.R., Rider C.V., Wilson V.S., Gray L.E. Cumulative effects of dibutyl phthalate and diethylhexyl phthalate on male rat reproductive tract development: Altered fetal steroid hormones and genes. Toxicological Sciences 2007, 99:190-202.
86. Hu G.X., Lin H., Sottas C.M., Morris D.J., Hardy M.P., Ge R.S. Inhibition of 11beta-hydroxysteroid dehydrogenase enzymatic activities by glycyrrhetinic acid in vivo supports direct glucocorticoid-mediated suppression of steroidogenesis in Leydig cells. Journal of Andrology 2008, 29:345-351.
87. Hu G.X., Zhao B., Chu Y., Li X.H., Akingbemi B.T., Zheng Z.Q., et al. Effects of methoxychlor and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane on 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase-3 activities in human and rat testes. International Journal of Andrology 2011, 34:138-144.
88. Hu G.X., Zhao B.H., Chu Y.H., Zhou H.Y., Akingbemi B.T., Zheng Z.Q., et al. Effects of genistein and equol on human and rat testicular 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities. Asian Journal of Andrology 2010, 12:519-526.
89. Hu G.X., Zhou H.Y., Li X.W., Chen B.B., Xiao Y.C., Lian Q.Q., et al. The (+)- and (-)-gossypols potently inhibit both 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 in human and rat testes. Journal of Steroid Biochemistry and Molecular Biology 2009, 115:14-19.
90. Hundertmark S., Dill A., Ebert A., Zimmermann B., Kotelevtsev Y.V., Mullins J.J., et al. Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice. Hormone and Metabolic Research 2002, 34:545-549.
91. Jang C., Obeyesekere V.R., Dilley R.J., Krozowski Z., Inder W.J., Alford F.P. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2007, 92:3314-3320.
92. Jensen A.A., Leffers H. Emerging endocrine disrupters: Perfluoroalkylated substances. International Journal of Andrology 2008, 31:161-169.
93. Jez J.M., Bennett M.J., Schlegel B.P., Lewis M., Penning T.M. Comparative anatomy of the aldo-keto reductase superfamily. The Biochemical Journal 1997, 326(Pt 3):625-636.
94. Johnson J.D., Gibson S.J., Ober R.E. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Fundamental and Applied Toxicology 1984, 4:972-976.
95. Kohn M.C., Parham F., Masten S.A., Portier C.J., Shelby M.D., Brock J.W., et al. Human exposure estimates for phthalates. Environmental Health Perspectives 2000, 108:A440-A442.
96. Kotelevtsev Y., Brown R.W., Fleming S., Kenyon C., Edwards C.R., Seckl J.R., et al. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. The Journal of Clinical Investigation 1999, 103:683-689.
97. Kratschmar D.V., Vuorinen A., Da Cunha T., Wolber G., Classen-Houben D., Doblhoff O., et al. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11beta-hydroxysteroid dehydrogenase type 2. Journal of Steroid Biochemistry and Molecular Biology 2011, 125:129-142.
98. Krozowski Z., Albiston A.L., Obeyesekere V.R., Andrews R.K., Smith R.E. The human 11 beta-hydroxysteroid dehydrogenase type II enzyme: Comparisons with other species and localization to the distal nephron. Journal of Steroid Biochemistry and Molecular Biology 1995, 55:457-464.
99. Krozowski Z., MaGuire J.A., Stein-Oakley A.N., Dowling J., Smith R.E., Andrews R.K. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. Journal of Clinical Endocrinology and Metabolism 1995, 80:2203-2209.
100. Krug A.W., Kopprasch S., Ziegler C.G., Dippong S., Catar R.A., Bornstein S.R., et al. Aldosterone rapidly induces leukocyte adhesion to endothelial cells: A new link between aldosterone and arteriosclerosis?. Hypertension 2007, 50:e156-e157.
101. Kyossev Z., Walker P.D., Reeves W.B. Immunolocalization of NAD-dependent 11 beta-hydroxysteroid dehydrogenase in human kidney and colon. Kidney International 1996, 49:271-281.
102. Labrie F., Luu-The V., Lin S.X., Labrie C., Simard J., Breton R., et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997, 62:148-158.
103. Lakshmi V., Monder C. Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex. Endocrinology 1988, 123:2390-2398.
104. Latif S.A., Shen M., Ge R.S., Sottas C.M., Hardy M.P., Morris D.J. Role of 11beta-OH-C(19) and C(21) steroids in the coupling of 11beta-HSD1 and 17beta-HSD3 in regulation of testosterone biosynthesis in rat Leydig cells. Steroids 2011, 76:682-689.
105. Lavery G.G., Walker E.A., Draper N., Jeyasuria P., Marcos J., Shackleton C.H., et al. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. The Journal of Biological Chemistry 2006, 281:6546-6551.
106. Lee R.H., Stanczyk F.Z., Stolz A., Ji Q., Yang G., Goodwin T.M. AKR1C1 and SRD5A1 messenger RNA expression at term in the human myometrium and chorioamniotic membranes. American Journal of Perinatology 2008, 25:577-582.
107. Lo S., Allera A., Albers P., Heimbrecht J., Jantzen E., Klingmuller D., et al. Dithioerythritol (DTE) prevents inhibitory effects of triphenyltin (TPT) on the key enzymes of the human sex steroid hormone metabolism. Journal of Steroid Biochemistry and Molecular Biology 2003, 84:569-576.
108. Loganathan S.N., Kannan K. Occurrence of bisphenol a in indoor dust from two locations in the eastern United States and implications for human exposures. Archives of Environmental Contamination and Toxicology 2011, 61:68-73.
109. Low S.C., Chapman K.E., Edwards C.R., Wells T., Robinson I.C., Seckl J.R. Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: The role of growth hormone patterns. The Journal of Endocrinology 1994, 143:541-548.
110. Luu-The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J., et al. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: Evidence of two mRNA species with distinct 5'-termini in human placenta. Molecular Endocrinology 1989, 3:1301-1309.
111. Luu-The V., Labrie C., Simard J., Lachance Y., Zhao H.F., Couet J., et al. Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genes. Molecular Endocrinology 1990, 4:268-275.
112. Ma X., Lian Q.Q., Dong Q., Ge R.S. Environmental inhibitors of 11beta-hydroxysteroid dehydrogenase type 2. Toxicology 2011, 285:83-89.
113. Marandici A., Monder C. Inhibition by glycyrrhetinic acid of rat tissue 11 beta-hydroxysteroid dehydrogenase in vivo. Steroids 1993, 58:153-156.
114. Mason J.I., Keeney D.S., Bird I.M., Rainey W.E., Morohashi K., Leers-Sucheta S., et al. The regulation of 3 beta-hydroxysteroid dehydrogenase expression. Steroids 1997, 62:164-168.
115. McKeever B.M., Hawkins B.K., Geissler W.M., Wu L., Sheridan R.P., Mosley R.T., et al. Amino acid substitution of arginine 80 in 17beta-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics. Biochimica et Biophysica Acta 2002, 1601:29-37.
116. McVey M.J., Cooke G.M. Inhibition of rat testis microsomal 3beta-hydroxysteroid dehydrogenase activity by tributyltin. Journal of Steroid Biochemistry and Molecular Biology 2003, 86:99-105.
117. Mendelson C.R., Gao E., Li J., Young P.P., Michael L.F., Alcorn J.L. Regulation of expression of surfactant protein-A. Biochimica et Biophysica Acta 1998, 1408:132-149.
118. Mercer W., Obeyesekere V., Smith R., Krozowski Z. Characterization of 11 beta-HSD1B gene expression and enzymatic activity. Molecular and Cellular Endocrinology 1993, 92:247-251.
119. Monder C. Corticosteroids, receptors, and the organ-specific functions of 11 beta-hydroxysteroid dehydrogenase. The FASEB Journal 1991, 5:3047-3054.
120. Monder C., Hardy M.P., Blanchard R.J., Blanchard D.C. Comparative aspects of 11 beta-hydroxysteroid dehydrogenase. Testicular 11 beta-hydroxysteroid dehydrogenase: Development of a model for the mediation of Leydig cell function by corticosteroids. Steroids 1994, 59:69-73.
121. Monder C., Lakshmi V. Evidence for kinetically distinct forms of corticosteroid 11 β-dehydrogenase in rat liver microsomes. Journal of Steroid Biochemistry 1989, 32:77-83.
122. Monder C., Stewart P.M., Lakshmi V., Valentino R., Burt D., Edwards C.R. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology 1989, 125:1046-1053.
123. Monder C., White P.C. 11 beta-hydroxysteroid dehydrogenase. Vitamins and Hormones 1993, 47:187-271.
124. Moore X.L., Hoong I., Cole T.J. Expression of the 11β-hydroxysteroid dehydrogenase 2 gene in the mouse. Kidney International 2000, 57:1307-1312.
125. Murono E.P., Derk R.C. The reported active metabolite of methoxychlor, 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane, inhibits testosterone formation by cultured Leydig cells from neonatal rats. Reproductive Toxicology 2005, 20:503-513.
126. Murono E.P., Derk R.C., de Leon J.H. Differential effects of octylphenol, 17beta-estradiol, endosulfan, or bisphenol A on the steroidogenic competence of cultured adult rat Leydig cells. Reproductive Toxicology 2001, 15:551-560.
127. Nakajima T., Yasuda K., Nishizawa M., Okada H., Yoshimura T., Ito S., et al. Expression of 20alpha-hydroxysteroid dehydrogenase mRNA in human endometrium and decidua. Endocrine Journal 2003, 50:105-111.
128. Nashev L.G., Schuster D., Laggner C., Sodha S., Langer T., Wolber G., et al. The UV-filter benzophenone-1 inhibits 17beta-hydroxysteroid dehydrogenase type 3: Virtual screening as a strategy to identify potential endocrine disrupting chemicals. Biochemical Pharmacology 2010, 79:1189-1199.
129. Obeid J., White P.C. Tyr-179 and Lys-183 are essential for enzymatic activity of 11 beta-hydroxysteroid dehydrogenase. Biochemical and Biophysical Research Communications 1992, 188:222-227.
130. Odermatt A., Arnold P., Stauffer A., Frey B.M., Frey F.J. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. The Journal of Biological Chemistry 1999, 274:28762-28770.
131. Odermatt A., Dick B., Arnold P., Zaehner T., Plueschke V., Deregibus M.N., et al. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. Journal of Clinical Endocrinology and Metabolism 2001, 86:1247-1252.
132. Ohno S., Nakajima Y., Nakajin S. Triphenyltin and Tributyltin inhibit pig testicular 17beta-hydroxysteroid dehydrogenase activity and suppress testicular testosterone biosynthesis. Steroids 2005, 70:645-651.
133. Ohshima M., Ohno S., Nakajin S. Inhibitory effects of some possible endocrine-disrupting chemicals on the isozymes of human 11beta-hydroxysteroid dehydrogenase and expression of their mRNA in gonads and adrenal glands. Environmental Sciences 2005, 12:219-230.
134. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environmental Health Perspectives 2007, 115:1298-1305.
135. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. Journal of Occupational and Environmental Medicine 1998, 40:614-622.
136. Oppermann U.C., Persson B., Jornvall H. Function, gene organization and protein structures of 11β-hydroxysteroid dehydrogenase isoforms. European Journal of Biochemistry 1997, 249:355-360.
137. O'Shaughnessy P.J., Baker P.J., Heikkila M., Vainio S., McMahon A.P. Localization of 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis-Androstenedione is the major androgen secreted by fetal/neonatal leydig cells. Endocrinology 2000, 141:2631-2637.
138. Ouchi K., Watanabe S. Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2002, 780:365-370.
139. Ozols J. Lumenal orientation and post-translational modifications of the liver microsomal 11 beta-hydroxysteroid dehydrogenase. The Journal of Biological Chemistry 1995, 270:2305-2312. [Published erratum appears in (1995 Apr 28) The Journal of Biological Chemistry, 270(17), 10360].
140. Pearce P.T., Lipkevicius O.R., Funder J.W. High affinity (type 1) aldosterone-binding sites in rat epididymis. Endocrinology 1986, 118:2072-2075.
141. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocrine Reviews 1997, 18:281-305.
142. Phillips D.M., Lakshmi V., Monder C. Corticosteroid 11β-dehydrogenase in rat testis. Endocrinology 1989, 125:209-216.
143. Piccirella S., Czegle I., Lizak B., Margittai E., Senesi S., Papp E., et al. Uncoupled redox systems in the lumen of the endoplasmic reticulum. Pyridine nucleotides stay reduced in an oxidative environment. The Journal of Biological Chemistry 2006, 281:4671-4677.
144. Poirier D. Inhibitors of 17 beta-hydroxysteroid dehydrogenases. Current Medicinal Chemistry 2003, 10:453-477.
145. Puranen T., Poutanen M., Ghosh D., Vihko P., Vihko R. Characterization of structural and functional properties of human 17 beta-hydroxysteroid dehydrogenase type 1 using recombinant enzymes and site-directed mutagenesis. Molecular Endocrinology 1997, 11:77-86.
146. Puranen T., Poutanen M., Ghosh D., Vihko R., Vihko P. Origin of substrate specificity of human and rat 17beta-hydroxysteroid dehydrogenase type 1, using chimeric enzymes and site-directed substitutions. Endocrinology 1997, 138:3532-3539.
147. Puranen T.J., Poutanen M.H., Peltoketo H.E., Vihko P.T., Vihko R.K. Site-directed mutagenesis of the putative active site of human 17 beta-hydroxysteroid dehydrogenase type 1. The Biochemical Journal 1994, 304(Pt 1):289-293.
148. Reinli K., Block G. Phytoestrogen content of foods-A compendium of literature values. Nutrition and Cancer 1996, 26:123-148.
149. Rheaume E., Lachance Y., Zhao H.F., Breton N., Dumont M., de Launoit Y., et al. Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Molecular Endocrinology 1991, 5:1147-1157.
150. Roberson A.E., Hyatt K., Kenkel C., Hanson K., Myers D.A. Interleukin 1beta regulates progesterone metabolism in human cervical fibroblasts. Reproductive Sciences 2011, 19:271-281.
151. Rodriguez-Bernaldo de Quiros A., Paseiro-Cerrato R., Pastorelli S., Koivikko R., Simoneau C., Paseiro-Losada P. Migration of photoinitiators by gas phase into dry foods. Journal of Agricultural and Food Chemistry 2009, 57:10211-10215.
152. Rooney S.A., Young S.L., Mendelson C.R. Molecular and cellular processing of lung surfactant. The FASEB Journal 1994, 8:957-967.
153. Rosler A., Silverstein S., Abeliovich D. A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. Journal of Clinical Endocrinology and Metabolism 1996, 81:1827-1831.
154. Sang G.W., Lorenzo B., Reidenberg M.M. Inhibitory effects of gossypol on corticosteroid 11-beta-hydroxysteroid dehydrogenase from guinea pig kidney: A possible mechanism for causing hypokalemia. Journal of Steroid Biochemistry and Molecular Biology 1991, 39:169-176.
155. Schutte B.C., Bjork B.C., Coppage K.B., Malik M.I., Gregory S.G., Scott D.J., et al. A preliminary gene map for the Van der Woude syndrome critical region derived from 900kb of genomic sequence at 1q32-q41. Genome Research 2000, 10:81-94.
156. Seckl J.R. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 1997, 62:89-94.
157. Seckl J.R. Prenatal glucocorticoids and long-term programming. European Journal of Endocrinology 2004, 151(Suppl. 3):U49-U62.
158. Seckl J.R., Holmes M.C. Mechanisms of disease: Glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nature Clinical Practice. Endocrinology & Metabolism 2007, 3:479-488.
159. Sharpe R.M. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicology Letters 2001, 120:221-232.
160. Shi Z., Zhang H., Liu Y., Xu M., Dai J. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicological Sciences 2007, 98:206-215.
161. Shimada H., Ohtaguro M., Miura K., Imamura Y. Inhibitory effects of diesel exhaust components and flavonoids on 20alpha-hydroxysteroid dehydrogenase activity in mouse tissues. Journal of Enzyme Inhibition and Medicinal Chemistry 2007, 22:445-449.
162. Simard J., Durocher F., Mebarki F., Turgeon C., Sanchez R., Labrie Y., et al. Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. The Journal of Endocrinology 1996, 150(Suppl.):S189-S207.
163. Sjoberg P., Bondesson U., Gray T.J., Ploen L. Effects of di-(2-ethylhexyl) phthalate and five of its metabolites on rat testis in vivo and in in vitro. Acta Pharmacologica et Toxicologica 1986, 58:225-233.
164. Smith R.E., Little P.J., Maguire J.A., Stein-Oakley A.N., Krozowski Z.S. Vascular localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme. Clinical and Experimental Pharmacology & Physiology 1996, 23:549-551.
165. Soaresam A., Guieysseb B., Jeffersona B., Cartmella E., Lestera J.N. Nonylphenol in the environment: A critical review on occurrence, fate, toxicity and treatment in wastewaters. Environment International 2008, 34:1033-1049.
166. Song D., Lorenzo B., Reidenberg M.M. Inhibition of 11 beta-hydroxysteroid dehydrogenase by gossypol and bioflavonoids. The Journal of Laboratory and Clinical Medicine 1992, 120:792-797.
167. Stewart P.M., Wallace A.M., Valentino R., Burt D., Shackleton C.H., Edwards C.R. Mineralocorticoid activity of liquorice: 11-Beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987, 2:821-824.
168. Suzuki S., Tsubochi H., Darnel A., Suzuki T., Sasano H., Krozowski Z.S., et al. Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in alveolar epithelial cells in rats. Endocrine Journal 2003, 50:445-451.
169. Svechnikov K., Supornsilchai V., Strand M.L., Wahlgren A., Seidlova-Wuttke D., Wuttke W., et al. Influence of long-term dietary administration of procymidone, a fungicide with anti-androgenic effects, or the phytoestrogen genistein to rats on the pituitary-gonadal axis and Leydig cell steroidogenesis. The Journal of Endocrinology 2005, 187:117-124.
170. Tang P.Z., Tsai-Morris C.H., Dufau M.L. Regulation of 3beta-hydroxysteroid dehydrogenase in gonadotropin-induced steroidogenic desensitization of Leydig cells. Endocrinology 1998, 139:4496-4505.
171. Tannin G.M., Agarwal A.K., Monder C., New M.I., White P.C. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. The Journal of Biological Chemistry 1991, 266:16653-16658.
172. Thomas J.L., Boswell E.L., Scaccia L.A., Pletnev V., Umland T.C. Identification of key amino acids responsible for the substantially higher affinities of human type 1 3beta-hydroxysteroid dehydrogenase/isomerase (3beta-HSD1) for substrates, coenzymes, and inhibitors relative to human 3beta-HSD2. The Journal of Biological Chemistry 2005, 280:21321-21328.
173. Thomas J.L., Duax W.L., Addlagatta A., Brandt S., Fuller R.R., Norris W. Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase. The Journal of Biological Chemistry 2003, 278:35483-35490.
174. Thomas J.L., Mason J.I., Brandt S., Spencer B.R., Norris W. Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity. The Journal of Biological Chemistry 2002, 277:42795-42801.
175. Thomas J.L., Myers R.P., Strickler R.C. Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5-4-ene-isomerase: Purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes. Journal of Steroid Biochemistry 1989, 33:209-217.
176. Troisi R., Hatch E.E., Titus-Ernstoff L., Hyer M., Palmer J.R., Robboy S.J., et al. Cancer risk in women prenatally exposed to diethylstilbestrol. International Journal of Cancer 2007, 121:356-360.
177. Usami N., Yamamoto T., Shintani S., Ishikura S., Higaki Y., Katagiri Y., et al. Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines. Biological and Pharmaceutical Bulletin 2002, 25:441-445.
178. Waddell B.J., Hisheh S., Krozowski Z.S., Burton P.J. Localization of 11β-hydroxysteroid dehydrogenase types 1 and 2 in the male reproductive tract. Endocrinology 2003, 144:3101-3106.
179. Walker E.A., Clark A.M., Hewison M., Ride J.P., Stewart P.M. Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1. The Journal of Biological Chemistry 2001, 276:21343-21350.
180. White P.C., Mune T., Agarwal A.K. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrine Reviews 1997, 18:135-156.
181. White P.C., Mune T., Rogerson F.M., Kayes K.M., Agarwal A.K. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Pediatric Research 1997, 41:25-29.
182. White P.C., Mune T., Rogerson F.M., Kayes K.M., Agarwal A.K. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Steroids 1997, 62:83-88.
183. Whorwood C.B., Mason J.I., Ricketts M.L., Howie A.J., Stewart P.M. Detection of human 11 beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Molecular and Cellular Endocrinology 1995, 110:R7-R12.
184. Wyrwoll C.S., Seckl J.R., Holmes M.C. Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology 2009, 150:1287-1293.
185. Xiao-feng Z., Nai-qiang Q., Jing Z., Zi L., Yang Z. Di (n-butyl) phthalate inhibits testosterone synthesis through a glucocorticoid-mediated pathway in rats. International Journal of Toxicology 2009, 28:448-456.
186. Yabaluri N., Bashyam M.D. Hormonal regulation of gluconeogenic gene transcription in the liver. Journal of Biosciences 2010, 35:473-484.
187. Yamaguchi H., Akitaya T., Yu T., Kidachi Y., Kamiie K., Noshita T., et al. Homology modeling and structural analysis of 11beta-hydroxysteroid dehydrogenase type 2. European Journal of Medicinal Chemistry 2011, 46:1325-1330.
188. Yamaguchi H., Akitaya T., Yu T., Kidachi Y., Kamiie K., Noshita T., et al. Molecular docking and structural analysis of cofactor-protein interaction between NAD(+) and 11beta-hydroxysteroid dehydrogenase type 2. Journal of Molecular Modelling 2012, 18:1037-1048.
189. Ye L., Su Z.J., Ge R.S. Inhibitors of testosterone biosynthetic and metabolic activation enzymes. Molecules 2011, 16:9983-10001.
190. Ye L., Zhao B., Cai X.H., Chu Y., Li C., Ge R.S. The inhibitory effects of perfluoroalkyl substances on human and rat 11beta-hydroxysteroid dehydrogenase 1. Chemico-Biological Interactions 2012, 195:114-118.
191. Yu Z.H., Chan H.C. Gossypol as a male antifertility agent-Why studies should have been continued. International Journal of Andrology 1998, 21:2-7.
192. Yuan K., Zhao B., Li X.W., Hu G.X., Su Y., Chu Y., et al. Effects of phthalates on 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities in human and rat testes. Chemico-Biological Interactions 2012, 195:180-188.
193. Zhang Y., Lin L., Cao Y., Chen B., Zheng L., Ge R.S. Phthalate levels and low birth weight: A nested case-control study of Chinese newborns. The Journal of Pediatrics 2009, 155:500-504.
194. Zhang J., Zuo Z., He C., Cai J., Wang Y., Chen Y., et al. Effect of tributyltin on testicular development in Sebastiscus marmoratus and the mechanism involved. Environmental toxicology and chemistry 2009, 28(7):1528-1535.
195. Zhao B., Chu Y., Hardy D.O., Li X.K., Ge R.S. Inhibition of 3beta- and 17beta-hydroxysteroid dehydrogenase activities in rat Leydig cells by perfluorooctane acid. Journal of Steroid Biochemistry and Molecular Biology 2010, 118:13-17.
196. Zhao B., Chu Y., Huang Y., Hardy D.O., Lin S., Ge R.S. Structure-dependent inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 activities by phthalates. Chemico-Biological Interactions 2010, 183:79-84.
197. Zhao B., Hu G.X., Chu Y., Jin X., Gong S., Akingbemi B.T., et al. Inhibition of human and rat 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities by perfluoroalkylated substances. Chemico-Biological Interactions 2010, 188:38-43.
198. Zhao B., Lian Q.Q., Chu Y., Hardy D.O., Li X.K., Ge R.S. The inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substances. Journal of Steroid Biochemistry and Molecular Biology 2011, 125:143-147.
199. Zheng L., Dong G.H., Jin Y.H., He Q.C. Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Archives of Toxicology 2009, 83:679-689.
200. Zhou H.Y., Hu G.X., Lian Q.Q., Morris D., Ge R.S. The metabolism of steroids, toxins and drugs by 11beta-hydroxysteroid dehydrogenase 1. Toxicology 2012, 292:1-12.